Navigation Links
Pharsight Achieves $7.6 Million In Quarterly Revenue
Date:5/8/2008

OLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited)

Three Months Ended Twelve Months Ended

March 31, March 31,

---------------------- ----------------------

2008 2007 2008 2007

--------- --------- --------- ---------

Revenues:

License $1,601 $1,425 $5,738 $5,402

Renewal 1,882 1,568 7,214 5,652

Maintenance 337 277 1,263 1,001

Services 3,770 3,989 14,127 13,037

--------- --------- --------- ---------

Total revenues 7,590 7,259 28,342 25,092

Cost of revenues 2,384 2,287 9,730 7,731

--------- --------- --------- ---------

Gross profit 5,206 4,972 18,612 17,361

Operating expenses:

Research and

development 1,239 1,255 4,787 4,295

Sales and marketing 1,944 1,749 6,924 6,330

General and

administrative 1,412 1,119 5,501 5,090

--------- --------- --------- ---------

Total operating

expenses 4,595 4,123 17,212 15,715

--------- --------- --------- ---------

Income from operations 611 849 1,400 1,646

Other income 59 105 430 372

--------- --------- ---------
'/>"/>

SOURCE Pharsight Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Pharsight Signs Two New DMX(R) License Customers
2. Pharsight to Present at B. Riley & Co. 9th Annual Las Vegas Investor Conference
3. Pharsight Makes Strong Contribution to Inaugural American Conference on Pharmacometrics
4. Pharsights Reporting and Analysis Services Business Unit to Leverage New Validated Data Management System
5. Pharsight Welcomes Newest Japanese PKS, AutoPilot Customer
6. Pharsight to Present at Jesup and Lamont 2008 Emerging Growth Stock Conference
7. Pharsight Achieves $7.4 Million in Quarterly Revenue
8. Pharsight Announces Fiscal Third Quarter 2008 Earnings Release Date and Conference Call
9. Pharsights Reporting and Analysis Services Business Reaches Quality Assurance Milestone
10. Pharsight Signs Third WinNonlin(R) AutoPilot(TM) Customer
11. Pharsight Announces 1-For-3 Reverse Stock Split
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... 26, 2014   Lycera Corp ., a ... medicines to treat autoimmune disease and cancer based ... the appointment of Harinder Singh , Ph.D., ... Dr. Singh will lead the board,s efforts to ... ongoing research programs and pipeline of therapies targeting ...
(Date:8/26/2014)... Genedata, a leading provider of ... science research, today announced the Genedata Screener® ... in Asia, Europe, and North America during September ... leading research organizations will gather for annual User ... and upcoming challenges in all areas of screening. ...
(Date:8/26/2014)... , Aug. 26, 2014  That,s Nice LLC, a ... today announced the formation of a new dedicated team ... The expanded team will combine current and new staff ... That,s Nice. Guy Tiene ... lead the team. Tiene was previously Director of Marketing ...
(Date:8/26/2014)... Formedix, the leading provider of clinical ... Transform for MARVIN: the latest addition to its ... line. It was developed in collaboration with Formedix ... the EDC and Clinical Data Management system. , ... allowing instantaneous visualization of MARVIN eCRFs as they ...
Breaking Biology Technology:Lycera Appoints Harinder Singh, Ph.D., as Chair of Scientific Advisory Board 2Lycera Appoints Harinder Singh, Ph.D., as Chair of Scientific Advisory Board 3Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 2Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 3That's Nice Announces Expanded Offering For Strategic Content And Public Relations 2That's Nice Announces Expanded Offering For Strategic Content And Public Relations 3Introducing Transform for MARVIN: Providing Further Flexibility for CROs and Sponsors in Partnership with XClinical 2
... of Panzem(R) NCD and Avastin(R) May Slow ... EntreMed, Inc.,(Nasdaq: ENMD ), a ... of cancer and inflammatory diseases, today,announced the ... 2 multi-center,study combining Panzem(R) NCD with Avastin(R) ...
... YORK, Jan. 28 The Medefield Group, the ... market research, consulting,and communications companies, is pleased to ... After another year of unprecedented growth,attributed to Medefield,s ... client base, the company is adding to its,ever-growing ...
... (Nasdaq: MNKD ), focused on discovering, developing and,commercializing ... present at the Wachovia Healthcare Conference on January 30, ... Boston, MA., Interested parties can access a link ... Investor Relations section of the Company,s website at, http://www.mannkindcorp.com ...
Cached Biology Technology:EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study 2EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study 3EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study 4Medefield Announces New Appointments to North American Business Unit 2
(Date:8/26/2014)... tent over a colony of harmful bacteria, biofilms ... Microorganisms protected in a biofilm pose a significant ... recalcitrance to treatment, and biofilm-protected bacteria account for ... humans and are 50 to 1,000 times more ... "In essence, we may have stumbled onto a ...
(Date:8/26/2014)... obtaining an unprecedented view of a type of ... of neurological illnesses, including Alzheimer,s disease, Parkinson,s disease, ... stroke. , The team of biologists at Cold ... Energy,s Advanced Photon Source at Argonne National Laboratory ... NMDA (N-methyl, D-aspartate) receptor should serve as template ...
(Date:8/26/2014)... New Zealand endemic tree has for the last 31 years ... Australian shrubs and small trees. A New Zealand botanist has ... astonishing cryptic diversity behind what was long considered a single ... journal PhytoKeys . , Known to botanists ... the many discoveries made in the north-western South Island of ...
Breaking Biology News(10 mins):Breakthrough antibacterial approach could resolve serious skin infections 2Breakthrough antibacterial approach could resolve serious skin infections 3Unprecedented detail of intact neuronal receptor offers blueprint for drug developers 2Unprecedented detail of intact neuronal receptor offers blueprint for drug developers 3And then there were 10 -- unexpected diversity in New Zealand kanuka genus Kunzea 2And then there were 10 -- unexpected diversity in New Zealand kanuka genus Kunzea 3
... than 10 percent each year from 2010 to 2050 ... fuels, but this is an unsustainable prospect. According to ... Governance, Economy and Ecology such a large growth rate ... otherwise each new power plant will simply cannibalize the ...
... (March 4, 2008) A unique dietary supplement called ... following experimental stroke. A nutritional supplement product, NutraStem also ... blueberry, green tea, vitamin D3 and carnosine extracts- a ... protecting against brain damage. Stroke is the third ...
... Research Council (BBSRC) funded scientists at the University of ... process of carbon dioxide fixation in plants. ... Proceedings of the National Academy of Sciences, increases our ... crop improvement and fourth generation biofuels. The mechanism, which ...
Cached Biology News:Nuclear cannibals 2Blueberry and green tea containing supplement protects against stroke damage 2Scientists uncover a novel mechanism that regulates carbon dioxide fixation in plants 2
... universal digital valve, just 8 mm in width. ... features in a single glass-reinforced, PBT (Polybutylene Terephthalate) ... in width. , Meets a range of pressure ... , Satisfies a 0.016 sccm leakage specification (0.2 ...
... The FilterMate is a compact, versatile system ... a 96- or 24-well microplates into a ... microplate liquid scintillation and gamma counter. The ... samples for applications such as cell proliferation, ...
... General description: Designed for use with ... CLS number is a new product number, ... If showing no availability yet, please order ... contact customer service for assistance. Comp Dim: ...
... G bind specifically to Fc regions of ... G conjugates are commonly used as affinity ... subtypes from serum, hybridoma ascites fluids, tissue ... reagents are also commonly used to capture ...
Biology Products: